Page 16 - Oncoextra Test News Today : Breaking News, Live Updates & Top Stories | Vimarsana

HH&L Acquisition (NYSE:HHLA – Get Free Report) and Exact Sciences (NASDAQ:EXAS – Get Free Report) are both financial services companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, profitability and analyst recommendations. Institutional and Insider Ownership 39.2% of HH&L […]

EFG Asset Management North America Corp. lowered its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 38,089 shares of the medical research company’s stock after selling […]

WoodTrust Financial Corp lessened its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 1.6% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,437 shares of the medical research company’s stock after selling 250 shares during the […]

Peregrine Capital Management LLC lowered its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 1.1% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 562,488 shares of the medical research company’s stock after selling 6,009 shares during the quarter. Exact Sciences accounts for […]

Sanford C. Bernstein assumed coverage on shares of Exact Sciences (NASDAQ:EXAS – Free Report) in a research report released on Thursday, MarketBeat reports. The firm issued an outperform rating and a $83.00 price target on the medical research company’s stock. A number of other brokerages also recently issued reports on EXAS. Piper Sandler lifted their […]